Table 3.
Follow‐up outcomes.
| Total (n = 505) | <80 years (n = 459) | ≥80 years (n = 46) | p‐Value | |
|---|---|---|---|---|
| 3‐month follow‐up TEE/CCT, No. (%) | 437 (86.5) | 397 (86.5) | 40 (87) | 1 |
| PDL | 0.84 | |||
| No PDL | 340 (77.8) | 308 (77.6) | 32 (80) | |
| Minor PDL | 97 (22.2) | 89 (22.4) | 8 (20) | |
| Major PDL | 0 (0) | 0 (0) | 0 (0) | |
| Device‐related thrombus, No. (%) | 5 (1.0) | 4 (0.9) | 1 (2.1) | 0.38 |
| Mean follow‐up time, M | 26.9 ± 9.1 | 27.1 ± 9.1 | 25.8 ± 8.7 | 0.7 |
| Pericardial effusion/cardiac tamponade, No. (%) | 6 (1.2) | 6 (1.3) | 0 (0) | 1 |
| AF recurrence, No. (%) | 113 (22.4) | 103 (22.4) | 10 (21.7) | 0.99 |
| Stroke/TIA, No. (%) | 10 (1.2) | 8 (1.7) | 2 (4.3) | 0.23 |
| Major bleeding, No. (%) | 1 (0.2) | 0 (0) | 1 (2.1) | 0.091 |
| All‐cause death, No. (%) | 16 (3.2) | 16 (3.5) | 0 (0) | 0.38 |
Abbreviations: AF, atrial fibrillation; CCT, cardiac computed tomography; M, month; PDL, peri‐device leak; TEE, transesophageal echocardiography; TIA, transient ischemic attack.